TapewireFind a company

person · Reporting owner

DAVENPORT FRED B JR

Disclosed activity across 1 company

Tapewire entity
20864
SEC CIK
0001181154

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Medpace Holdings, Inc.MEDP · Entity 3327DirectorAugust 19, 2026August 21, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Medpace Holdings, Inc.

Report date August 19, 2026 · Filed August 21, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect3,798 Ending reported balance After 2026-08-19 transaction · row 4
4 source rows · reconciled sequence

Row 1 · 2026-08-19 · Exercise / conversion · Acquired 1,903 · Balance 5,401

Row 2 · 2026-08-19 · Exercise / conversion · Acquired 3,858 · Balance 9,259

Row 3 · 2026-08-19 · Exercise / conversion · Acquired 1,822 · Balance 11,081

Row 4 · 2026-08-19 · Sale · Disposed 7,283 · Balance 3,798

F1: The reported price is a weighted average price. The shares were sold in multiple transactions ranging from $605.59 to $607.202. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $133.87 · Expires 2029-05-20Direct0 Reported balance After 2026-08-19 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2026-08-19 · Exercise / conversion · Disposed 1,903 · Balance 0

F3: The option vested in full on 05/18/2023.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $84.36 · Expires 2027-05-15Direct0 Reported balance After 2026-08-19 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2026-08-19 · Exercise / conversion · Disposed 3,858 · Balance 0

F4: The option vested in full on 05/13/2021.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $164.68 · Expires 2028-05-14Direct0 Reported balance After 2026-08-19 transaction · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · 2026-08-19 · Exercise / conversion · Disposed 1,822 · Balance 0

F5: The option vested in full on 05/14/2022.

Common StockSEC Table I · non-derivativeIndirectBy Trust2,000 Reported balance Holding disclosure · report date 2026-08-19 · row 5 Holding and transaction disclosures are not merged.
1 source row

Row 5 · Balance 2,000

F2: Owned by trust for the benefit of the Reporting Person.

Filing footnotes · ownership attribution and instrument terms

F1: The reported price is a weighted average price. The shares were sold in multiple transactions ranging from $605.59 to $607.202. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

F2: Owned by trust for the benefit of the Reporting Person.

F3: The option vested in full on 05/18/2023.

F4: The option vested in full on 05/13/2021.

F5: The option vested in full on 05/14/2022.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 19, 2026 Filed Aug 21, 2026 20:11 UTC Medpace Holdings, Inc. MEDP · Entity 3327 Exercise / conversionStock Option (Right to Buy) · Derivative 1,822 $0.00 Strike: $164.68 $0.00
Disclosure

SEC source: 0000892251-26-000123 · form4.xml · derivative · entry 8

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,822 shares

Expires 2028-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vested in full on 05/14/2022.

Read SEC document
August 19, 2026 Filed Aug 21, 2026 20:11 UTC Medpace Holdings, Inc. MEDP · Entity 3327 Exercise / conversionStock Option (Right to Buy) · Derivative 3,858 $0.00 Strike: $84.36 $0.00
Disclosure

SEC source: 0000892251-26-000123 · form4.xml · derivative · entry 7

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,858 shares

Expires 2027-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested in full on 05/13/2021.

Read SEC document
August 19, 2026 Filed Aug 21, 2026 20:11 UTC Medpace Holdings, Inc. MEDP · Entity 3327 Exercise / conversionStock Option (Right to Buy) · Derivative 1,903 $0.00 Strike: $133.87 $0.00
Disclosure

SEC source: 0000892251-26-000123 · form4.xml · derivative · entry 6

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,903 shares

Expires 2029-05-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested in full on 05/18/2023.

Read SEC document
August 19, 2026 Filed Aug 21, 2026 20:11 UTC Medpace Holdings, Inc. MEDP · Entity 3327 SaleCommon Stock 7,283 $606.15 $4,414,590.45
Disclosure

SEC source: 0000892251-26-000123 · form4.xml · nonDerivative · entry 4

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,798

F1 · price: The reported price is a weighted average price. The shares were sold in multiple transactions ranging from $605.59 to $607.202. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

Read SEC document
August 19, 2026 Filed Aug 21, 2026 20:11 UTC Medpace Holdings, Inc. MEDP · Entity 3327 Exercise / conversionCommon Stock 1,822 $164.68 $300,046.96
Disclosure

SEC source: 0000892251-26-000123 · form4.xml · nonDerivative · entry 3

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,081

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 19, 2026 Filed Aug 21, 2026 20:11 UTC Medpace Holdings, Inc. MEDP · Entity 3327 Exercise / conversionCommon Stock 3,858 $84.36 $325,460.88
Disclosure

SEC source: 0000892251-26-000123 · form4.xml · nonDerivative · entry 2

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,259

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 19, 2026 Filed Aug 21, 2026 20:11 UTC Medpace Holdings, Inc. MEDP · Entity 3327 Exercise / conversionCommon Stock 1,903 $133.87 $254,754.61
Disclosure

SEC source: 0000892251-26-000123 · form4.xml · nonDerivative · entry 1

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,401

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2026 Filed May 18, 2026 21:04 UTC Medpace Holdings, Inc. MEDP · Entity 3327 GrantStock Option (Right to Buy) · Derivative 1,110 $0.00 Strike: $415.27 $0.00
Disclosure

SEC source: 0001181154-26-000002 · wk-form4_1779138265.xml · derivative · entry 3

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,110

Underlying: Common Stock · 1,110 shares

Expires 2033-05-15

F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 21:46 UTC Medpace Holdings, Inc. MEDP · Entity 3327 Exercise / conversionStock Option (Right to Buy) · Derivative 6,472 $0.00 Strike: $54.99 $0.00
Disclosure

SEC source: 0001181154-25-000004 · wk-form4_1762206393.xml · derivative · entry 4

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,472 shares

Expires 2026-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested in full on May 14, 2020.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 21:46 UTC Medpace Holdings, Inc. MEDP · Entity 3327 SaleCommon Stock 5,972 $581.88 $3,474,987.36
Disclosure

SEC source: 0001181154-25-000004 · wk-form4_1762206393.xml · nonDerivative · entry 2

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,498

F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $580.53 to $585.26. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 21:46 UTC Medpace Holdings, Inc. MEDP · Entity 3327 Exercise / conversionCommon Stock 6,472 $54.99 $355,895.28
Disclosure

SEC source: 0001181154-25-000004 · wk-form4_1762206393.xml · nonDerivative · entry 1

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,470

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 16, 2025 Filed May 20, 2025 20:33 UTC Medpace Holdings, Inc. MEDP · Entity 3327 GrantStock Option (Right to Buy) · Derivative 1,224 $0.00 Strike: $305.66 $0.00
Disclosure

SEC source: 0001668397-25-000065 · wk-form4_1747773172.xml · derivative · entry 3

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,224

Underlying: Common Stock · 1,224 shares

Expires 2032-05-16

F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

Read SEC document
April 24, 2025 Filed Apr 28, 2025 20:39 UTC Medpace Holdings, Inc. MEDP · Entity 3327 Exercise / conversionStock Option (Right to Buy) · Derivative 4,710 $0.00 Strike: $57.17 $0.00
Disclosure

SEC source: 0001668397-25-000061 · wk-form4_1745872747.xml · derivative · entry 4

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,710 shares

Expires 2025-08-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested in full on May 16, 2019.

Read SEC document
April 24, 2025 Filed Apr 28, 2025 20:39 UTC Medpace Holdings, Inc. MEDP · Entity 3327 SaleCommon Stock 1,712 $301.82 $516,715.84
Disclosure

SEC source: 0001668397-25-000061 · wk-form4_1745872747.xml · nonDerivative · entry 2

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,998

Read SEC document
April 24, 2025 Filed Apr 28, 2025 20:39 UTC Medpace Holdings, Inc. MEDP · Entity 3327 Exercise / conversionCommon Stock 4,710 $57.17 $269,270.70
Disclosure

SEC source: 0001668397-25-000061 · wk-form4_1745872747.xml · nonDerivative · entry 1

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,710

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 17, 2024 Filed May 21, 2024 20:32 UTC Medpace Holdings, Inc. MEDP · Entity 3327 GrantStock Option (Right to Buy) · Derivative 953 $0.00 Strike: $393.30 $0.00
Disclosure

SEC source: 0001668397-24-000105 · wk-form4_1716323543.xml · derivative · entry 2

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 953

Underlying: Common Stock · 953 shares

Expires 2031-05-17

F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

Read SEC document
May 19, 2023 Filed May 23, 2023 20:24 UTC Medpace Holdings, Inc. MEDP · Entity 3327 GrantStock Option (Right to Buy) · Derivative 1,769 $0.00 Strike: $210.88 $0.00
Disclosure

SEC source: 0000892251-23-000059 · form4.xml · derivative · entry 2

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,769

Underlying: Common Stock · 1,769 shares

Expires 2030-05-19

F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

Read SEC document
May 20, 2022 Filed May 24, 2022 20:16 UTC Medpace Holdings, Inc. MEDP · Entity 3327 GrantStock Option (Right to Buy) · Derivative 1,903 $0.00 Strike: $133.87 $0.00
Disclosure

SEC source: 0001567619-22-011617 · doc1.xml · derivative · entry 2

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,903

Underlying: Common Stock · 1,903 shares

Expires 2029-05-20

F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

Read SEC document
February 17, 2022 Filed Feb 22, 2022 21:15 UTC Medpace Holdings, Inc. MEDP · Entity 3327 PurchaseCommon Stock 500 $145.80 $72,900.00
Disclosure

SEC source: 0001567619-22-005254 · doc1.xml · nonDerivative · entry 1

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 2,000

F1 · ownership.nature: Owned by trust for the benefit of the Reporting Person.

Read SEC document
May 14, 2021 Filed May 18, 2021 20:29 UTC Medpace Holdings, Inc. MEDP · Entity 3327 GrantStock Option (Right to Buy) · Derivative 1,822 $0.00 Strike: $164.68 $0.00
Disclosure

SEC source: 0001567619-21-010623 · doc1.xml · derivative · entry 2

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,822

Underlying: Common Stock · 1,822 shares

Expires 2028-05-14

F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

Read SEC document
May 15, 2020 Filed May 19, 2020 20:13 UTC Medpace Holdings, Inc. MEDP · Entity 3327 GrantStock Option (Right to Buy) · Derivative 3,858 $0.00 Strike: $84.36 $0.00
Disclosure

SEC source: 0001567619-20-010757 · doc1.xml · derivative · entry 2

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,858

Underlying: Common Stock · 3,858 shares

Expires 2027-05-15

F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

Read SEC document
May 17, 2019 Filed May 21, 2019 20:54 UTC Medpace Holdings, Inc. MEDP · Entity 3327 GrantStock Option (Right to Buy) · Derivative 6,472 $0.00 Strike: $54.99 $0.00
Disclosure

SEC source: 0001567619-19-011792 · doc1.xml · derivative · entry 2

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,472

Underlying: Common Stock · 6,472 shares

Expires 2026-05-17

F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

Read SEC document
August 13, 2018 Filed Aug 15, 2018 20:50 UTC Medpace Holdings, Inc. MEDP · Entity 3327 GrantStock Option (Right to Buy) · Derivative 4,710 $0.00 Strike: $57.17 $0.00
Disclosure

SEC source: 0001567619-18-001191 · doc1.xml · derivative · entry 2

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,710

Underlying: Common Stock · 4,710 shares

Expires 2025-08-13

F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.